$43.12
-1.27-2.86%
Dern. MÀJ: Oct 19, 7:11 AM
$43.62
-0.77-1.73%
Veracyte (VCYT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
fiscal year (2026) a publié ses dernières prévisions le $590M - $596M pour Veracyte {{epsDirection}}. La société a prévu un chiffre d'affaires compris entre {{epsPriorRange}} et {{revenueDirection}} pour la période.
Par rapport aux prévisions précédentes, {{newestDate}} {{directionSummary}} ses prévisions de chiffre d'affaires ont été revues à la baisse, passant d'une fourchette précédente de undefined à undefined.
undefined a publié undefined mises à jour de ses recommandations entre undefined et undefined. undefined
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.41 | $0.31 | $0.36 | $0.27 |
| Actual | $0.54 | $0.52 | $0.53 | $0.51 |
| Surprise | +31.7% | +67.7% | +47.2% | +88.9% |
| Revenue | ||||
| Estimate | $144.3M | $130.4M | $136.9M | $124.9M |
| Actual | $150.3M | $139.1M | $140.6M | $131.9M |
| Surprise | +4.20% | +6.65% | +2.70% | +5.60% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.38 | $0.42 | $0.34 | $0.38 |
| Revenue | ||||
| Consensus | $147.1M | $157.3M | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $0.54 | $0.41 | 31.7 % |
| Q1 | May 5, 2026 | $0.52 | $0.31 | 67.7 % |
| Q4 | Feb 25, 2026 | $0.53 | $0.36 | 47.2 % |
| Q3 | Nov 4, 2025 | $0.51 | $0.27 | 88.9 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $150.32M | $144.27M | 4.20 % |
| Q1 | May 5, 2026 | $139.07M | $130.40M | 6.65 % |
| Q4 | Feb 25, 2026 | $140.64M | $136.94M | 2.70 % |
| Q3 | Nov 4, 2025 | $131.90M | $124.91M | 5.60 % |